Jeff Conroy :: Partner

Mr. Conroy has over 20 years of experience in biotechnology business development and commercialization strategy. Much of his recent work has been in transaction advisory services and alliance development, including in-licensing, partnering, and commercialization of preclinical, clinical and marketed pharmaceutical products.

Mr. Conroy has served as the CEO of Innovative Biologics, Inc, a small molecule anti-infectives company developing inhibitors of pore-forming toxins for Methicillin Resistant Staphylococcus aureus (MRSA) infection. Prior to Adjuvant, Mr. Conroy held general management and marketing leadership positions with Thermo BioAnalysis, a division of Thermo Electron (NYSE:TMO). Prior to Thermo, Mr. Conroy held sales, marketing and business development positions at Transgenic Sciences Corp. and Abbott Laboratories.

Mr. Conroy is a member of the Licensing Executives Society and serves on the Board of the Virginia Biotechnology Association. He holds adjunct faculty appointments at Georgetown University Medical School and Virginia Polytechnic Institute and State University. Mr. Conroy holds a BS in Finance from Providence College.

Edmund "Morrie" Ruffin, MA :: Partner

Morrie has 17 years of experience in the Biotech and Healthcare industries. Prior to joining Adjuvant Global Advisors, he was the Chief Executive Officer of LifeTech Innovations, LLC a business development consulting firm based in Bethesda, MD.Ê Prior to his position at LTI, Mr. Ruffin was Executive Vice President of Capital Formation and Business Development at the Biotechnology Industry Organization (BIO), the largest trade organization representing the biotech and drug development industries. Joining BIO in 1994 as one of its original employees, Mr. Ruffin was responsible for building the organization's global business development and investor outreach programs focused on helping companies raise capital and identify strategic partnering and licensing opportunities. This BIO business development franchise is now the largest in the world, with operations in the US, Europe, and Japan.

In addition to his business development work at BIO, Mr. Ruffin was responsible for leading the industryÕs capital formation advocacy efforts with a focus on economic incentives to promote investment in early stage biotech and med-tech businesses. Mr. Ruffin was a founder and board member of the Interoperable Informatics Infrastructure Consortium (I3C), an international standards setting body for the bioinformatics industry.

Prior to joining BIO, Mr. Ruffin worked for U.S. Senator Arlen Specter for five years as his senior legislative assistant. Prior to that, he spent approximately five years working in varying capacities, including policy analyst, at Systems Planning Corporation International and the Center for Strategic and International Studies. Mr. Ruffin received his MA in International Studies & Economics from the Johns Hopkins School for Advanced International Studies (SAIS) and his BA from the University of Virginia.

Ian Wisenberg :: Senior Consultant

Ian Wisenberg has more than 25 years experience in international business with an emphasis in finance, capital formation and business development. He currently serves as ChinaBio's Senior Vice President for Strategic Development and is a CFO consultant with CFO Connect.

Ian's prior experience includes serving as Managing Partner for BioGlobal Consulting Group, a strategic advisory and financial solutions practice for life science companies. Prior to that, Ian served as the Senior Vice President of Business Development and CFO of BIOCOM, the world's largest regional life science trade organization. Bringing a broad portfolio of expertise, Ian has a solid track record in Capital Development initiatives aimed at establishing strategic financial partnerships with local, national and international financing institutions. He was also responsible for the VC incubator in San Diego. Of equal significance is his ability to foster international relations with government agencies and private institutions.

Mr. Wisenberg also serves on the Board of Directors for a local San Diego biotech company and is treasurer for the San Diego Venture Group. Prior to BIOCOM, he was Vice President of finance and administration, as well as interim President, Secretary and treasurer of Aerocast, Inc., a secured broadband media streaming company. Mr. Wisenberg holds a Bachelor of Commerce Degree in accounting from Cape Town University and is a Certified Public Accountant.